Files
Download Full Text (8.0 MB)
Contents
- Malignant brain tumors a new target for gene therapy
- Benign pituitary tumors threaten endocrine and nervous systems
- New guidebook helps patients and caregivers cope with advanced cancer
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Publication Date
1996
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Yung, W. K. Alfred; Sawaya, Raymond; McCutcheon, Ian E.; Eng, David; Greisinger, Anthony; Telek, Stephanie; Bisanz, Annette; Friend, Keith E.; Genetic Therapy; Brain Neoplasms; Glioblastoma; Surgical Procedures, Operative; Radiotherapy; Antineoplastic Agents; Genes, Transgenic, Suicide; Clinical Trials as Topic; Neoplasm Micrometastasis; Herpes Simplex; Ganciclovir; Retroviridae; Adenoviridae; Stereotaxic Techniques; Genes, p53; Terminally Ill; Adaptation, Psychological; Quality of Life; Caregivers; Pituitary Neoplasms; Tomography, X-Ray Computed; Magnetic Resonance Imaging; Prolactinoma; Growth Hormone-Secreting Pituitary Adenoma; Bromocriptine; Octreotide.
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Deming, Stephanie P.; Hale, Kathryn L.; and Williams, Vickie J., "OncoLog, Volume 41, Number 01, January-March 1996" (1996). OncoLog MD Anderson's Report to Physicians (All issues). 56.
https://openworks.mdanderson.org/oncolog/56
Conditions Governing Access
Open
